Double transplant attack on aggressive blood cancer

NCT ID NCT00466674

Summary

This study tested a two-step transplant approach for patients under 65 with aggressive myeloma. After an initial transplant, patients who had a partial response received a second, gentler transplant from a donor. The goal was to better control the disease and improve survival by using the donor's immune system to fight the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Mohamad Sobh

    Lyon, 69437, France

Conditions

Explore the condition pages connected to this study.